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IN SILICO SCREENING TO PREDICT CHONDROCYTE HYPERTROPHY
USING A SEMIQUANTITATIVE GENE NETWORK MODEL
J. Kerkhofs y,z, J. Leijten y, F.P. Luyten y, L. Geris y,z. yKU Leuven, Leuven,
Belgium; zU.Liege, Liege, Belgium
Purpose: In development, chondrocyte hypertrophy is a crucial and
well-studied step in endochondral ossiﬁcation. Hypertrophy may also
play a role in pathophysiological processes, including osteoarthritis. We
employ a computational approach to estimate the effect of individual
factors in this complex process.
Methods:We have combined information gleaned from a high number
of publications on chondrocyte differentiation into a gene regulatory
network of 46 factors and over 150 interactions. This network can
estimate the stability of proliferative chondrocytes/permanent cartilage
(stable state with SOX9 activity) and hypertrophic chondrocytes (stable
state with RUNX2 activity) by employing 2 measures. A ﬁrst measure is
a Monte Carlo analysis that assesses stability in the face of random
initial conditions, the second modiﬁes stable states to estimate the
sensitivity to perturbation.
Results: For each factor, these qualitative measures are calculated in
silico under knockout and overexpression conditions and compared to
the wild type situation. This enables screening of the effects of all
incorporated factors on cartilage homeostasis, differentiation and
pathogenesis via the initiation of hypertrophy. Indeed, our gene net-
work analysis indicated multiple candidate genes for the development
of osteoarthritis. Factors that amplify the SOX9 attractor basin include
TGFb, PPR, IGF-I, and PKA. The presence of RAS, IHH, GLI2 and FGF is
required for the Runx2 stable state. Using a literature study, we corro-
borated several of the proposed factors.
Conclusions: In silico screening of overexpression and knockout pres-
ents a novel strategy to improve bone and cartilage tissue engineering
approaches, and can be used to propose a list of putative therapeutic
targets for e.g. osteoarthritis.
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CD109 INHIBITS TRANSFORMING GROWTH FACTOR-BETA SIGNALING
AND EXTRACELLULAR MATRIX PROTEIN PRODUCTION IN HUMAN
CHONDROCYTES
Y. Chi, J. Antoniou, A. Philip. McGill Univ., Montreal, QC, Canada
Purpose: Transforming growth factor-beta (TGF-b) is a multifunctional
growth factor that maintains cartilage integrity and function by pro-
moting synthesis of extracellular matrix (ECM) proteins such as type II
collagen. Dysregulation of TGF-b action is implicated in joint diseases
such as osteoarthritis (OA). TGF-b initiates its action by binding to the
type II TGF-b receptor which then phosphorylates and activates type I
receptor (Activin-receptor Like Kinase 5, ALK5) which in turn phos-
phorylates the intracellular proteins, Smad2/3. The activated Smad2/3
then forms a heteromeric complex with Smad4 and translocates to the
nucleus leading to regulation of gene transcription. Our group has
reported the discovery of CD109 as a novel TGF-b co-receptor and has
shown that CD109 is a potent negative regulator of TGF-b signaling and
action in skin. The objectives of the current study were: (i) to determine
whether CD109 is expressed in human articular chondrocytes, and (ii)
to examine whether CD109 regulates TGF-b signaling and ECM protein
expression in human articular chondrocytes.
Methods: Articular chondrocytes were isolated from normal cartilage
harvested from adult patients with traumatic open joint injury who
have no history of OA or from osteoarthritic cartilage obtained from OA
patients at hip replacement surgery. CD109 expression in chondrocytes
was determined by Western blot and CD109 function was analyzed by
blocking CD109 expression using CD109-speciﬁc siRNA and measuring
TGF-b-induced transcriptional activity, Smad phosphorylation, and
production of ECM proteins, type II collagen and plasminogen activator
inhibitor-1 (PAI-1).
Results: Our results show that CD109 is expressed in human articular
chondrocytes and that CD109 markedly decreases type I TGF-b receptor
(ALK5) expression and inhibits TGF-b-induced phosphorylation of
Smad3, Smad3-driven transcriptional activity, and expression of type II
collagen and PAI-1.
Conclusions: Our ﬁndings suggest that CD109 negatively regulates
TGF-b signaling and TGF-b-induced ECM protein production in human
articular chondrocytes, and may play an important role in maintaining
cartilage function and integrity.224
A SIGNIFICANT ROLE FOR THE JNK PATHWAY IN REGULATING
INTERLEUKIN 1 INDUCED-AGGRECAN DEGRADATION IN HUMAN
ARTICULAR CHONDROCYTES
H.M. Ismail, K. Yamamoto, T. Vincent, H. Nagase, L. Troeberg,
J. Saklatvala. Kennedy Inst. of Rheumatology, Univ. of Oxford, Oxford,
United Kingdom
Purpose: Aggrecan, the main proteoglycan of articular cartilage, ena-
bles the tissue to resist compression. In health, aggrecan synthesis is
balanced by its turnover. In arthritis, there is a net degradation, thought
mainly to be due to an increase in proteolytic activity in the joint. Loss of
aggrecan is a feature of arthritic cartilage and can be induced exper-
imentally by various stimuli including pro-inﬂammatory cytokines such
as IL1. IL1 induces speciﬁc aggrecan cleavages at sites where ADAMTS
proteinases characteristically act. Here, we aimed to identify the
intracellular signalling pathways by which IL1 controls aggrecan deg-
radation by human chondrocytes, and the mechanism of this control,
particularly focusing on the regulation of extracellular aggrecanases by
the cell receptor Low density lipoprotein receptor-related protein 1
(LRP1).
Methods: We developed a cell-based assay that combines siRNA-
induced knockdown with an aggrecan degradation assay. Human
articular chondrocytes were overlaid with bovine aggrecan in combi-
nation with siRNAs against key proteins in the IL1 signalling pathway.
Knockdown efﬁciency was analysed by Western blotting or by RT-PCR.
NFkB activation was inhibited by infection with an IkB virus. Aggrecan
fragments in the culture medium were identiﬁed by antibodies to the
AGEG and ARGS cleavage neo-epitopes. Total aggrecanase activity and
TIMP3 levels were measured by ELISA. LRP-1 shedding was analysed by
western blotting.
Results: By siRNA, we show that ADAMTS5 is the major aggrecanase in
human chondrocytes following IL1 stimulation. The TRAF6/TAK1/MKK4
signalling axis is essential for IL1 induced aggrecan degradation, while
NFkB is not. Of the three MAPK kinases; ERK, p38 and JNK, only JNK2
showed a signiﬁcant role in aggrecan degradation. JNK2 had no effect
on mRNA levels of Adamts5. IL1 caused aggrecanase activity to appear
in the medium in a JNK2-dependent manner, possibly by reducing its
endocytosis, since IL-1 caused JNK2-dependent shedding of LRP-1. In
unstimulated cells, basal levels of aggrecanases were kept low by con-
tinuous endocytic activitity through LRP1.
Conclusions: The results demonstrate an essential role for the signaling
axis TRAF6/TAK1/MKK4/JNK2 in IL1 induced aggrecanolysis. Knock-
down of JNK2 signiﬁcantly reduced the detectable levels of aggreca-
nases in culture medium and could control its endocytosis. JNK2 could
exert its effects on aggrecan degradation through regulation of LRP1-
mediated endocytosis of aggrecanses.Chondrocyte Biology & Biochemistry
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TRPC6 PLAYS A ROLE IN CXCR2-MEDIATED CHONDROCYTE
PHENOTYPIC STABILITY
J. Sherwood y, J. Bertrand y, F. Dell'Accio z, T. Pap y. yUniv. Hosp. Münster,
Münster, Germany; zQueen Mary Univ. of London, London, United
Kingdom
Purpose: We have recently demonstrated that ELRþ CXC chemokines,
which signal via the CXCR2 receptor, are produced by healthy chon-
drocytes and are retained within the cartilage matrix via interactions
with heparan sulfate proteoglycans. Here, they act to support articular
cartilage homeostasis by inducing AKT phosphorylation, thus increas-
ing chondrocyte survival, SOX9 expression and extracellular matrix
production, particularly during conditions of physiological challenge,
indicated by increased chondrocyte apoptosis and cartilage degradation
in CXCR2-/- mice following destabilization of the medial meniscus.
Interestingly, the transient receptor potential channel 6 (TRPC6) ion
channel has been shown to be a speciﬁc mediator of CXCR2 driven cell
migration via AKT signaling. This project aims to investigate whether
TRPC6 is involved in the mechanism of CXCR2-mediated control of
chondrocyte phenotypic stability via calcium signaling pathways.
Methods: Costal chondrocytes were isolated from CXCR2-/- mice,
TRPC6-/- mice and their wild type littermates and expanded in
